249 related articles for article (PubMed ID: 27198154)
1. Regulation of miR-200c and miR-141 by Methylation in Prostate Cancer.
Lynch SM; O'Neill KM; McKenna MM; Walsh CP; McKenna DJ
Prostate; 2016 Sep; 76(13):1146-59. PubMed ID: 27198154
[TBL] [Abstract][Full Text] [Related]
2. Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.
Wang X; Gao H; Ren L; Gu J; Zhang Y; Zhang Y
BMC Cancer; 2014 May; 14():308. PubMed ID: 24885368
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
4. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.
Vatanmakanian M; Steffan JJ; Koul S; Ochoa AC; Chaturvedi LS; Koul HK
Front Endocrinol (Lausanne); 2023; 14():1156120. PubMed ID: 37900138
[TBL] [Abstract][Full Text] [Related]
5. DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer.
Mancini M; Grasso M; Muccillo L; Babbio F; Precazzini F; Castiglioni I; Zanetti V; Rizzo F; Pistore C; De Marino MG; Zocchi M; Del Vescovo V; Licursi V; Giurato G; Weisz A; Chiarugi P; Sabatino L; Denti MA; Bonapace IM
Carcinogenesis; 2021 Dec; 42(12):1449-1460. PubMed ID: 34687205
[TBL] [Abstract][Full Text] [Related]
6. The functional significance of microRNA-145 in prostate cancer.
Zaman MS; Chen Y; Deng G; Shahryari V; Suh SO; Saini S; Majid S; Liu J; Khatri G; Tanaka Y; Dahiya R
Br J Cancer; 2010 Jul; 103(2):256-64. PubMed ID: 20588276
[TBL] [Abstract][Full Text] [Related]
7. Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.
Li Y; Nie Y; Tu S; Wang H; Zhou Y; Du Y; Cao J; Ye M
Oncol Rep; 2016 Oct; 36(4):2108-16. PubMed ID: 27498672
[TBL] [Abstract][Full Text] [Related]
8. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
9. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation silences miR-132 in prostate cancer.
Formosa A; Lena AM; Markert EK; Cortelli S; Miano R; Mauriello A; Croce N; Vandesompele J; Mestdagh P; Finazzi-Agrò E; Levine AJ; Melino G; Bernardini S; Candi E
Oncogene; 2013 Jan; 32(1):127-34. PubMed ID: 22310291
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.
Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Grönberg H; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Clin Cancer Res; 2014 Apr; 20(8):2169-81. PubMed ID: 24737792
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
Xia L; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W; Sha J
Biomed Pharmacother; 2020 Apr; 124():109863. PubMed ID: 31986411
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion.
Li Y; Kong D; Ahmad A; Bao B; Dyson G; Sarkar FH
Epigenetics; 2012 Aug; 7(8):940-9. PubMed ID: 22805767
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
16. Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition.
Liu J; Li M; Wang Y; Luo J
J Drug Target; 2017 Aug; 25(7):645-652. PubMed ID: 28391715
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
[TBL] [Abstract][Full Text] [Related]
18. SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop.
Huang K; Tang Y
Cell Death Dis; 2021 Feb; 12(2):188. PubMed ID: 33589600
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.
Cheng Y; Kim JW; Liu W; Dunn TA; Luo J; Loza MJ; Kim ST; Zheng SL; Xu J; Isaacs WB; Chang BL
Prostate; 2009 Feb; 69(3):327-35. PubMed ID: 19035483
[TBL] [Abstract][Full Text] [Related]
20. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
